Division of Digestive and Liver Diseases.
Department of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
J Clin Gastroenterol. 2022 Feb 1;56(2):e121-e125. doi: 10.1097/MCG.0000000000001502.
The goal of this study was to evaluate the relationship between pretransplant delayed gastric emptying (DGE) and posttransplant acute cellular rejection (ACR) in lung transplant recipients.
DGE is very prevalent (23% to 91%) after lung transplantation but pretransplant prevalence has not been well studied. DGE may lead to poor posttransplant outcomes by predisposing to microaspiration. Pretransplant testing for DGE may help identify patients at risk for negative posttransplant outcomes including ACR.
A retrospective review of a prospectively collected database of consecutive patients undergoing prelung transplant evaluation at a tertiary referral center from 2010 to 2015 was performed. Patients with pretransplant gastric emptying scintigraphy were included in the study. ACR diagnosis was made using International Society for Heart and Lung Transplantation (ISHLT) histologic criteria. Typical gastroparesis symptoms at the time of gastric emptying scintigraphy and pretransplant 24-hour pH impedance monitoring (MII-pH) data was collected. Logistic regression was used for multivariate analysis. Subgroup analyses were performed to account for gastroesophageal reflux (GER).
A total of 83 subjects (18 with DGE, 51.8% male, mean age: 53.6 y) met the criteria for inclusion. Patients with DGE were more likely to have typical symptoms of gastroparesis, though 61.1% of DGE patients were asymptomatic. ACR was more prevalent in patients with DGE (33.3% vs. 12.3%, P=0.04). This correlation was independent of GER as measured by MII-pH on subgroup analysis (75% vs. 14.3%, n=0.02).
Lung transplant recipients with pretransplant DGE have a higher incidence of ACR, independent of GER. Routine pretransplant testing for DGE may help identify patients at greater risk for adverse posttransplant outcomes as the majority of patients with DGE are asymptomatic.
本研究旨在评估肺移植受者移植前延迟胃排空(DGE)与移植后急性细胞排斥(ACR)之间的关系。
DGE 在肺移植后非常普遍(23%至 91%),但移植前的患病率尚未得到很好的研究。DGE 可能通过易导致微吸入而导致移植后预后不良。DGE 的移植前检测可能有助于识别易发生包括 ACR 在内的移植后不良结局的患者。
对 2010 年至 2015 年在一家三级转诊中心进行肺移植前评估的连续患者的前瞻性收集数据库进行了回顾性分析。纳入了进行移植前胃排空闪烁显像的患者。ACR 诊断采用国际心肺移植协会(ISHLT)组织学标准。在胃排空闪烁显像时和移植前 24 小时 pH 阻抗监测(MII-pH)时收集典型胃轻瘫症状的数据。使用逻辑回归进行多变量分析。进行亚组分析以考虑胃食管反流(GER)。
共有 83 名患者(18 名 DGE,51.8%为男性,平均年龄:53.6 岁)符合纳入标准。DGE 患者更有可能出现典型的胃轻瘫症状,尽管 61.1%的 DGE 患者无症状。DGE 患者的 ACR 更常见(33.3%比 12.3%,P=0.04)。这种相关性在亚组分析中独立于 MII-pH 测量的 GER(75%比 14.3%,n=0.02)。
移植前 DGE 的肺移植受者 ACR 发生率更高,与 GER 无关。常规进行移植前 DGE 检测可能有助于识别移植后不良结局风险较高的患者,因为大多数 DGE 患者无症状。